Group One Trading’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20 Buy
+2
New +$19 ﹤0.01% 7462
2025
Q4
Hold
0
7975
2025
Q3
Hold
0
8285
2025
Q2
Hold
0
7829
2025
Q1
Sell
-74
Closed -$1.53K 8175
2024
Q4
$1.4K Buy
+74
New +$2.19K ﹤0.01% 6826
2023
Q4
Sell
-242
Closed -$32.1K 7979
2023
Q3
$32.1K Sell
242
-19
-7% -$2.95K ﹤0.01% 5489
2023
Q2
$47.9K Hold
261
﹤0.01% 5306
2023
Q1
$43.9K Buy
261
+13
+5% +$2.74K ﹤0.01% 4948
2022
Q4
$53.6K Sell
248
-65
-21% -$24.5K ﹤0.01% 4940
2022
Q3
$121K Sell
313
-21
-6% -$11.9K ﹤0.01% 4599
2022
Q2
$140K Buy
334
+18
+6% +$8.7K ﹤0.01% 4657
2022
Q1
$187K Buy
316
+111
+54% +$82.5K ﹤0.01% 4862
2021
Q4
$227K Buy
205
+136
+197% +$296K ﹤0.01% 4958
2021
Q3
$265K Sell
69
-139
-67% -$438K ﹤0.01% 4890
2021
Q2
$599K Buy
+208
New +$491K ﹤0.01% 4018

Other funds holding PAVM

Group One Trading's PAVM Position: Q1 2026 in Review

Group One Trading opened a new position in PAVmed (PAVM) in Q1 2026: 2 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #7462 among its holdings. This is a return to the name: Group One Trading previously reported a position in PAVM as recently as Q4 2024.

Group One Trading first reported a position in PAVM in Q2 2021 and has held it in 12 quarters since. The position peaked at $599K in Q2 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • Group One Trading held 2 shares of PAVmed worth $20 as of Q1 2026.
  • PAVmed was a new Group One Trading position in Q1 2026.
  • PAVmed made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7462 holding.
  • Group One Trading first reported a position in PAVmed in Q2 2021 and has held it in 12 quarters since.
  • Group One Trading's PAVmed position peaked at $599K in Q2 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.